Drug
Nabilone
Nabilone: highest development phase Post-Market, developed by Bausch Health. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| nabilone NCT00480181 | Post-Market | Neuropathic Pain |
| Nabilone NCT00384410 | Phase 2 | Pain |
Latest
No recent events.
Follow Nabilone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.